The present disclosure relates to physiological monitoring. More specifically, this disclosure relates to systems, methods, and apparatuses for reducing error in repeated non-invasive physiological measurements.
Non-invasive physiological monitoring may require placement of a non-invasive sensor on a tissue site. Changes in positioning of the sensor of the tissue site can introduce error to measurements due to variations in tissue composition.
In some examples, a system for aligning a tissue site of a patient to a sensor is disclosed. The system can include: a first anchoring component configured to couple to the tissue site of a patient, wherein the first anchoring component can include: a first surface configured to couple to the tissue site; a first opening configured to allow at least one non-invasive sensor to perform a physiological measurement of the tissue site; and at least one securing component to secure the first anchoring component to a second anchoring component associated with the at least one non-invasive sensor such that the tissue site is maintained within a range of vertical distances from the non-invasive sensor and is secured to disallow horizontal movement within a range of horizontal distances.
The first surface can couple to the tissue site using an adhesive.
The adhesive can be configured to couple the first surface to the tissue site for a period comprising at least one day.
The first surface can have a curvature similar to that of the tissue site.
The at least one securing component can include one or more latches, slides, or snaps.
The at least one securing component can include at least one wall of the first opening having a first slope, and the second anchoring component can include at least one wall having the first slope.
The at least one securing component can be configured to mate with a mating component associated with the second anchoring component.
The second anchoring component can be configured to mate with a third anchoring component.
The third anchoring component can include a portion of the non-invasive sensor.
The first opening can include a keyhole shape.
In some examples, a method for aligning a tissue site to a sensor is disclosed. The method can include: attaching a first anchoring component to the tissue site; connecting the first anchoring component to a second anchoring component attached to a sensor head, such that the sensor head is aligned with an opening in the first anchoring component; and securing the first and second anchoring components such that the tissue site maintains generally a vertical distance away from the sensor head.
Connecting the first anchoring component to the second anchoring component can include moving at least one catch into at least one slide.
Connecting the first anchoring component to the second anchoring component can include moving the second anchoring component into a keyhole fitting.
Securing the first anchoring component to the second component can be completed by a user moving the tissue site in relation to the second anchoring component.
The first and second anchoring components can be secured such that the tissue site generally restricts horizontal movement of the tissue site.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features are discussed herein. It is to be understood that not necessarily all such aspects, advantages or features will be embodied in any particular embodiment of the invention and an artisan would recognize from the disclosure herein a myriad of combinations of such aspects, advantages or features.
The following drawings and the associated descriptions are provided to illustrate embodiments of the present disclosure and do not limit the scope of the claims.
Overview
Examples disclosed herein relate to systems and methods for anchoring a tissue site for a physiological measurement. These systems can be used, for example, on transmission-based spectroscopy technologies or reflectance-based spectroscopy technologies.
Many devices place an alligator-type or clothespin-type clip to align a finger with a sensor for measuring physiological parameters. For example, current pulse oximetry and co-oximetry noninvasive sensors can require a user to place his or her finger in a clothespin-type clip. This action can require both hands of the patient or a clinician to ensure accurate placement. Additionally, placement accuracy of the emitter and detector windows relative to the patient's measurement site can be difficult to achieve with an alligator clip type sensor. Placement of the windows is important in obtaining a value when measuring.
The anchoring system described herein may improve the placement of transmission and reflectance based spectroscopic sensors at a patient tissue site. For example, in the case of a finger, the anchoring system may allow for consistent and ergonomic finger placement with relation to the sensor and more consistent sensor measurements due to ease of use and increased precision of tissue site placement.
In some examples, an anchoring system can include one or more anchoring components. At least one anchoring component can be configured to both couple to the tissue site of a patient and a component associated with a physiological sensor. The anchoring system may be configured to hold the tissue site in place using the anchoring component(s) while a physiological measurement is performed. Additionally or alternatively, the anchoring system can be configured to couple to a sensor head such that the same tissue site can be measured after removal and replacement of a tissue site in relation to the sensor.
In some examples, an anchoring component can include a tissue anchor, such as described with reference to
Example Anchoring System
A sensor head, such as described herein, can include components or aspects of a noninvasive sensor, invasive sensor, or minimally invasive sensor configured to measure one or more physiological parameters from a tissue site of a patient. A physiological parameter can include, but is not limited to, a heart rate, respiration rate, analyte concentration, temperature, the like or a combination thereof. In some examples, a noninvasive sensor can include an optical sensor, such as a Raman sensor, OCT sensor, or other optical sensor. In some examples, an invasive or minimally invasive sensor can include a blood analyte monitor, such as a continuous glucose monitor or other disease management system, such as described with reference to U.S. application Ser. No. 17/161,528, filed Jan. 28, 2021, titled “REDUNDANT STAGGERED GLUCOSE SENSOR DISEASE MANAGEMENT SYSTEM,” the contents of which is hereby incorporated by reference in its entirety. It is of note that while in some examples reference may be made to a sensor, a sensor head, or other sensor components, systems and methods described herein can additionally or alternatively refer to other components or devices configured for close placement to a tissue site, such as a component configured to deliver medication to a user, such as an insulin pump, and the configurations disclosed herein may be used for attaching a medication delivery system to a user. Additionally or alternatively, systems and methods described herein may be applicable to any system that requires secure attachment of a device to a tissue site of a patient for a short or prolonged period of time.
An anchoring surface 102 may be configured to fit to a tissue site of a patient. A tissue site of a patient can include, but is not limited to, a nail bed, fingernail, toenail, abdomen, arm, or other tissue site suitable for measuring physiological parameters using a noninvasive, invasive, or minimally invasive physiological sensor. In some examples, the anchoring surface 102 may have a contour similar to a tissue site of a patient. For example, a tissue site may be a fingernail and the anchoring surface 102 may have a contour such that the anchoring surface 102 sits approximately flush against the fingernail. In some examples, the contour of the anchoring surface 102 can be fitted to a patient and/or a tissue site. For example, the anchoring surface 102 can be contoured to a particular fingernail of a patient, such as a patient's ring finger. In another example, the anchoring surface 102 can be contoured to fit more than one tissue site. For example, the anchoring surface 102 can be contoured generally to fit against more than one fingernail type, such as a thumb and ring finger or other combination of tissue sites. In some examples, the contour of the anchoring surface 102 may be molded to a particular tissue site. For example, the anchoring surface 102 may include one or more moldable materials. In another example, the anchoring surface 102 may be generically contoured to fit a generic tissue site type, such as a typical human thumb nail.
In some examples, one or more coupling materials can be applied to the anchoring surface 102 to improve the fit of the anchoring surface 102 to the tissue site. For example, the coupling material can include a gel, optical coupling material, or other moldable or semi-moldable material. In some examples, a coupling material may be configured to permanently or semi-permanently attach the anchoring surface 102 to the tissue site. Such a coupling material can include a glue, tape, or other attachment material.
The size of the anchoring surface 102 may be large enough to provide a coupling site to the tissue of the patient. For example, where the tissue site is a fingernail, the size anchoring surface 102 can be a sizable portion of the fingernail, such as 10%, 20%, 50%, or 80% of the nail bed or more or less of the nail bed. Additionally or alternatively, the size of the anchoring surface 102 may be large enough to couple with one or more sensor heads, such as described with reference to U.S. patent application Ser. No. 17/004,663, filed Aug. 27, 2020, titled “NON-INVASIVE MEDICAL MONITORING DEVICE FOR BLOOD ANALYTE MEASUREMENTS,” the contents of which is hereby incorporated by reference in its entirety. For example, the anchoring surface 102 can be at least the size of a sensor head configured to couple with the anchoring component.
An interlock component 104 can include a mechanism to aid in coupling a sensor to the tissue anchor 100. The interlock component 104 can have any number of interlock styles, including, but not limited to, keyhole interlocks, hinged interlocks, bolt interlocks, etc. As described with reference to
The opening 106 can be an appropriate shape and size to couple with a sensor head such that the sensor head can sense the tissue site directly. For example, an opening 106 may allow for a clear optical path to the tissue site to perform a physiological measurement with one or more sensors. The opening 106 can be positioned at any location in the tissue anchor 100 so as to provide access to the tissue site. In some examples, there may be more than one opening 106 to provide multiple points of access to the tissue site. The size of the opening 106 can be of a suitable size for a required measurement of the tissue site. For example, a sensor may require a one square cm{circumflex over ( )}2 area to perform a measurement. The opening 106 may be at least the one square cm{circumflex over ( )}2 to allow for a proper measurement using the appropriate sensor. In another example, the opening 106 may be large enough for more than one sensor to perform a measurement. For example, a sensor head can include multiple sensor types. Each sensor type may require the same or a different area of the tissue site to perform measurements. The opening 106 may be of sufficient size to accommodate one or all of the coupled sensors. In another examples, the tissue anchor 100 may be configured to couple to more than one sensor head type requiring different area amounts of tissue site for measurement. The opening 106 may be large enough to accommodate one or more of the coupled sensor head types.
A shape of the opening 106 can be any number of shapes, such as a circle, square, triangle, or other geometry. The shape of the opening 106 can include a shape associated with the interlock mechanism 104. For example, the shape of the opening may mirror the shape of the interlock mechanism 104. In another example, the shape of the opening 106 may mirror the shape of one or more sensor heads configured to couple to the tissue anchor 100. For example, a sensor head may be circular and the opening 106 may also be circular.
The tissue anchor attachment 206 can couple with the tissue anchor 208 via an interlocking mechanism, such as interlock component 104 illustrated in
In some examples, the tissue anchor component 206 may be coupled to or be a part of a sensor head (not shown). In other examples, the interlocking mechanism 200 can include a sensor head attachment 204. The senor head attachment 204 can be part of or couple with a sensor head (not shown). For example, the sensor head attachment 204 can be permanently or removably attached to a sensor head so as to allow the sensor head to couple to the tissue anchor attachment 206 or tissue anchor 208. The sensor head attachment 204 can be configured to mate with the tissue anchor 208 and/or tissue anchor attachment 206. For example, the sensor head attachment 204 can be configured to removably lock onto the tissue anchor attachment 206 or otherwise secure the sensor head to the tissue anchor attachment 206 or tissue anchor 208.
In some examples, the sensor head attachment 200 may be of a size and shape to receive sensor head and/or lock a sensor head in place. For example, the interlocking mechanism 200 may have a sensor window 202 to receive a sensor head. The sensor window 202 can align with the tissue anchor opening 106 (such as shown, for example in
The tissue anchor attachment 206 and sensor head attachment 204 may contain markings 210 or other indicators to signify whether the components are in a locked or unlocked position. For example, the tissue anchor attachment 206 or other component of the interlocking mechanism 200 may be configured to lock onto another component. The locking mechanism may have an open and a close configuration. In an open configuration, a first marking 210 of a first mating component, such as, for example, a tissue anchor component 206, may align with another marking 212 of a second mating component, such as, for example a sensor head attachment 204. In a closed configuration, a second marking 210 of a first mating component, such as, for example, a tissue anchor component 206, may align with another marking 212 of a second mating component, such as, for example a sensor head attachment 204. However, other markings or indicators of alignment, attachment, or locking state are possible.
Though the illustration depicts an interlocking mechanism with more than one component, the interlocking mechanism can be one component or comprised of multiple components. It should also be understood that, in the case of various components, each component can be separated completely or merely have their positions adjusted relative to each other. The interlocking mechanism 200 may be operated automatically, semi-automatically, manually, or mechanically.
Example Coupling Components
An interlocking mechanism 300 can include one or more interlocking components 303. The interlocking components 303 can include mating components, such as at least one catch 302 and at least one slide 301 or other components for maintaining the position and orientation of two or more components of the anchoring system. In some embodiments, the number of catches 302 may match the number of slides 301. In other examples, there may be a different number of catches 302 than slides 301. For example, an interlocking component may include multiple slides 301 and a single catch 302. In another example, an interlocking component may include multiple catches 302 and a single slide 301. Additionally or alternatively, there may be more than one type of mating component for maintaining a position and orientation of two or more portions of the anchoring system. For example, the interlocking components 303 can include some combination of catches and slides, threaded components, clips, latches, teethed components, grooved components, locking rings, pins, tightening components, or other securing components. Additionally or alternatively, a coupling may be accomplished by matching a first geometric shape of a first component with a second geometric shape of a second component, as discussed with reference to
In some examples, slide 301 can be an elongated piece that contacts the catch 302. The slide 301 and catch 302 can remain in contact as the components transition between a locked and unlocked position. The slide 301 may contain a groove on one end that is shaped to accept the catch 302. Though the illustration shows a round catch 302, it is to be understood that the catch 302 can be any shape.
In some examples, the mating components may be part of different interlocking components. For example, a tissue anchor 304 can include one or more slides 301 and/or one or more catches 302. Additionally or alternatively, a sensor attachment 306 can include one or more mating slides 301 and/or catches 302. However, other mating components are possible. For example, a first interlocking component, such as a sensor attachment 306, may have one or more female and/or male mating components. In another example, a second interlocking component, such as a tissue anchor 304 may have one or more female and/or mating components that may mate with the mating components of the first interlocking component. For example, where the mating components include a catch 302 and a slide 301, a catch 302 may fit into a slide 301.
The interlocking mechanism 200 can transition between a lock and unlocked position either manually or mechanically. Although
Example Keyhole Coupling
The tissue anchor 404 can include a mating structure 408 and one or more open areas 406, 410. An open area 406 can be of a suitable size and shape through which a sensor, such as a Raman sensor, can measure physiological parameters. For example, the open area 406 can be large enough to include the spot size of an excitation source that may be part of the Raman sensor. Additionally or alternatively, the open area 406 can be large enough to allow for the excitation source of the sensor to scan the tissue site or to account for movement of the excitation source during use or manufacture. In some examples, the open area 406 can be part of the mating structure 408 such that the one or more portions of the open area 406 can be capable of accepting one or more portions of the interlocking component 402. In some examples, the open area may have a diameter d substantially similar to the diameter of an interlock component 402 such that the interlock component 402 fits snugly in the open area 406.
Additionally or alternatively, an open area 410 may connect with the open area 406. The open area 410 may be of a different size and shape than the open area 406 such that an interlock component 402 may be received without significantly restraining the interlock component 402. Advantageously, the open area 410 may thus allow the tissue anchor 404 to receive the interlock attachment 402 more easily so that a user can move the interlock attachment 402 into place in the open area 406, such as illustrated in
A mating structure 408 of the tissue anchor 404 can be a structure capable of mating with an interlock component 402 that may be associated with a sensor head. For example, the mating structure 408 may have a geometric shape, such as a truncated cone. An associated interlock component 402 may also have a truncated cone shape. The shapes and sizes of the interlock component 402 and mating structure 408 may mate such that the position or orientation of the interlock component 402 may be substantially secured in a vertical and/or horizontal direction with respect to the tissue site 422.
The tissue anchor 404 can be coupled to the tissue site of a patient or user by any suitable means. For example, the tissue anchor 404 can be attached to the tissue site of a patient using a coupling material 420, such as a permanent or temporary adhesive, by permanent or temporary implantation, via a wearable device, or other suitable means of temporarily, semi-permanently, or permanently securing a component to a tissue site. In some examples, the tissue anchor 404 may be secured to a tissue site of a patient via a semi-permanent adhesive capable of securing the attachment component for a day or more. For example, the tissue anchor 404 may be secured to a tissue site with a medical adhesive, glue, tape, or other means of adhering components to a tissue site.
Example Sensor Head Attachment
The tissue anchor 404 can include an attachment structure 508. The attachment structure 508 can include a form and structure capable of mating with an interlock component associated with a sensor head. For example, the attachment structure 508 can include a central raised portion capable of fitting into a mating cavity of similar size and shape to the central raised portion. Additionally or alternatively, the attachment structure 508 can include one or more walls capable of securing the tissue anchor 500 within a mating cavity that may be part of an interlocking component (such as the interlocking component 602 of
An interlock component 602 can include a cavity 608 of a size and shape capable of accepting the tissue anchor 404 in whole or in part. Advantageously, the cavity 608 may serve as a primary or additional securing mechanism for the securing a sensor head 604 to a tissue anchor 404. However, other securing mechanisms are also possible and a sensor head 604 and tissue anchor 404 may be secured together with the aid of the interlock component 602 using any number of securing mechanisms, such as those described above.
The interlock component 602 may have one or more surfaces 610 of a similar curvature to the curvature of a surface of the tissue anchor 600. The curvature of the surfaces of the interlock component 602 and tissue anchor 404 can be of similar curvature to that of the area of the measured tissue site. For example, the tissue site may be a finger nail and the curvature of can follow the approximate curvature of the finger nail. In some examples, the curvature can be specific to the curvature of the tissue site of the user. For example, surfaces of the interlock component 602 and tissue anchor 404 can be molded, formed, or otherwise shaped according to the shape of the tissue site. In other examples, the curvature can be generic to the approximate curvature of the tissue site of the user. For example, surfaces of the interlock component 602 and tissue anchor 404 can be molded, formed, or otherwise shaped according to the approximate curvature of an adult human finger nail where the tissue site is a finger nail.
An interlock component 602 may be configured to couple to or be a part of a sensor head 604. Additionally or alternatively, the interlock component 602 may be a part of a system or device for receiving a tissue site at a sensor device. The interlock component 602 may be interchangeable such that more than one tissue anchor 404 may mate to a sensor head 604 or more than one sensor head 604 may mate to a tissue anchor 404. For example, a sensor head, such as a Raman sensor head, may have a unique footprint or geometry, differing from a different sensor head, such as an absorbance sensor head. Additionally, a tissue site may have a unique geometry. For example, a thumbnail may have a different curvature and area than a ring fingernail. An interlock component 602 may be configured to attach to a particular sensor head, such as a Raman sensor and a particular tissue site, such as an index finger. If a user desires to place the Raman sensor on their ring finger instead of their index finger, instead of reconfiguring the Raman sensor head, an interlock component 602 may be replaced that may be configured for placement on the ring finger. In another example, a user may desire to utilize a different sensor at the same tissue site, such as a Raman sensor instead of an absorbance sensor. The user may thus replace the interlock component 602 such that the Raman sensor may mate with the tissue anchor as opposed to the absorbance sensor.
Example Method of Use
Terminology
The term “and/or” herein has its broadest least limiting meaning which is the disclosure includes A alone, B alone, both A and B together, or A or B alternatively, but does not require both A and B or require one of A or one of B. As used herein, the phrase “at least one of” A, B, “and” C should be construed to mean a logical A or B or C, using a non-exclusive logical or.
The following description is merely illustrative in nature and is in no way intended to limit the disclosure, its application, or uses. For purposes of clarity, the same reference numbers will be used in the drawings to identify similar elements. It should be understood that steps within a method may be executed in different order without altering the principles of the present disclosure.
Features, materials, characteristics, or groups described in conjunction with a particular aspect, embodiment, or example are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features or steps are mutually exclusive. The protection is not restricted to the details of any foregoing embodiments. The protection extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of protection. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms. Furthermore, various omissions, substitutions and changes in the form of the methods and systems described herein may be made. Those skilled in the art will appreciate that in some embodiments, the actual steps taken in the processes illustrated or disclosed may differ from those shown in the figures. Depending on the embodiment, certain of the steps described above may be removed, others may be added. For example, the actual steps or order of steps taken in the disclosed processes may differ from those shown in the figures. Depending on the embodiment, certain of the steps described above may be removed, others may be added. For instance, the various components illustrated in the figures may be implemented as software or firmware on a processor, controller, ASIC, FPGA, or dedicated hardware. Hardware components, such as processors, ASICs, FPGAs, and the like, can include logic circuitry. Furthermore, the features and attributes of the specific embodiments disclosed above may be combined in different ways to form additional embodiments, all of which fall within the scope of the present disclosure.
User interface screens illustrated and described herein can include additional or alternative components. These components can include menus, lists, buttons, text boxes, labels, radio buttons, scroll bars, sliders, checkboxes, combo boxes, status bars, dialog boxes, windows, and the like. User interface screens can include additional or alternative information. Components can be arranged, grouped, displayed in any suitable order.
Although the present disclosure includes certain embodiments, examples and applications, it will be understood by those skilled in the art that the present disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments or uses and obvious modifications and equivalents thereof, including embodiments which do not provide all of the features and advantages set forth herein. Accordingly, the scope of the present disclosure is not intended to be limited by the specific disclosures of preferred embodiments herein, and may be defined by claims as presented herein or as presented in the future.
Conditional language, such as “can,” “could,” “might,” or “may,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, or steps. Thus, such conditional language is not generally intended to imply that features, elements, or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements, or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Further, the term “each,” as used herein, in addition to having its ordinary meaning, can mean any subset of a set of elements to which the term “each” is applied.
Conjunctive language such as the phrase “at least one of X, Y, and Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to convey that an item, term, etc. may be either X, Y, or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require the presence of at least one of X, at least one of Y, and at least one of Z.
Language of degree used herein, such as the terms “approximately,” “about,” “generally,” and “substantially” as used herein represent a value, amount, or characteristic close to the stated value, amount, or characteristic that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, “generally,” and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount. As another example, in certain embodiments, the terms “generally parallel” and “substantially parallel” refer to a value, amount, or characteristic that departs from exactly parallel by less than or equal to 15 degrees, 10 degrees, 5 degrees, 3 degrees, 1 degree, or 0.1 degree.
The scope of the present disclosure is not intended to be limited by the specific disclosures of preferred embodiments in this section or elsewhere in this specification, and may be defined by claims as presented in this section or elsewhere in this specification or as presented in the future. The language of the claims is to be interpreted broadly based on the language employed in the claims and not limited to the examples described in the present specification or during the prosecution of the application, which examples are to be construed as non-exclusive.
The present application claims priority to U.S. Provisional Patent Application No. 62/985,164, filed on Mar. 4, 2020, the contents of which are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4960128 | Gordon et al. | Oct 1990 | A |
4964408 | Hink et al. | Oct 1990 | A |
5319355 | Russek | Jun 1994 | A |
5337744 | Branigan | Aug 1994 | A |
5341805 | Stavridi et al. | Aug 1994 | A |
5377676 | Vari et al. | Jan 1995 | A |
5431170 | Mathews | Jul 1995 | A |
5436499 | Namavar et al. | Jul 1995 | A |
5456252 | Vari et al. | Oct 1995 | A |
5479934 | Imran | Jan 1996 | A |
5482036 | Diab et al. | Jan 1996 | A |
5494043 | O'Sullivan et al. | Feb 1996 | A |
5533511 | Kaspari et al. | Jul 1996 | A |
5590649 | Caro et al. | Jan 1997 | A |
5602924 | Durand et al. | Feb 1997 | A |
5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
5638818 | Diab et al. | Jun 1997 | A |
5645440 | Tobler et al. | Jul 1997 | A |
5671914 | Kalkhoran et al. | Sep 1997 | A |
5726440 | Kalkhoran et al. | Mar 1998 | A |
D393830 | Tobler et al. | Apr 1998 | S |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5747806 | Khalil et al. | May 1998 | A |
5750994 | Schlager | May 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5760910 | Lepper, Jr. et al. | Jun 1998 | A |
5890929 | Mills et al. | Apr 1999 | A |
5919134 | Diab | Jul 1999 | A |
5987343 | Kinast | Nov 1999 | A |
5997343 | Mills et al. | Dec 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6010937 | Karam et al. | Jan 2000 | A |
6027452 | Flaherty et al. | Feb 2000 | A |
6040578 | Malin et al. | Mar 2000 | A |
6066204 | Haven | May 2000 | A |
6115673 | Malin et al. | Sep 2000 | A |
6124597 | Shehada et al. | Sep 2000 | A |
6128521 | Marro et al. | Oct 2000 | A |
6129675 | Jay | Oct 2000 | A |
6144868 | Parker | Nov 2000 | A |
6152754 | Gerhardt et al. | Nov 2000 | A |
6184521 | Coffin, IV et al. | Feb 2001 | B1 |
6232609 | Snyder et al. | May 2001 | B1 |
6241683 | Macklem et al. | Jun 2001 | B1 |
6253097 | Aronow et al. | Jun 2001 | B1 |
6255708 | Sudharsanan et al. | Jul 2001 | B1 |
6280381 | Malin et al. | Aug 2001 | B1 |
6285896 | Tobler et al. | Sep 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6317627 | Ennen et al. | Nov 2001 | B1 |
6321100 | Parker | Nov 2001 | B1 |
6334065 | Al-Ali et al. | Dec 2001 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6368283 | Xu et al. | Apr 2002 | B1 |
6411373 | Garside et al. | Jun 2002 | B1 |
6415167 | Blank et al. | Jul 2002 | B1 |
6430437 | Marro | Aug 2002 | B1 |
6430525 | Weber et al. | Aug 2002 | B1 |
6463311 | Diab | Oct 2002 | B1 |
6470199 | Kopotic et al. | Oct 2002 | B1 |
6487429 | Hockersmith et al. | Nov 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6525386 | Mills et al. | Feb 2003 | B1 |
6526300 | Kiani et al. | Feb 2003 | B1 |
6534012 | Hazen et al. | Mar 2003 | B1 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6584336 | Ali et al. | Jun 2003 | B1 |
6587196 | Stippick et al. | Jul 2003 | B1 |
6587199 | Luu | Jul 2003 | B1 |
6597932 | Tian et al. | Jul 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6635559 | Greenwald et al. | Oct 2003 | B2 |
6639668 | Trepagnier | Oct 2003 | B1 |
6640116 | Diab | Oct 2003 | B2 |
6640117 | Makarewicz et al. | Oct 2003 | B2 |
6658276 | Kiani et al. | Dec 2003 | B2 |
6661161 | Lanzo et al. | Dec 2003 | B1 |
6697656 | Al-Ali | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
RE38492 | Diab et al. | Apr 2004 | E |
6738652 | Mattu et al. | May 2004 | B2 |
6760607 | Al-Ali | Jul 2004 | B2 |
6788965 | Ruchti et al. | Sep 2004 | B2 |
6816241 | Grubisic | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6850787 | Weber et al. | Feb 2005 | B2 |
6850788 | Al-Ali | Feb 2005 | B2 |
6876931 | Lorenz et al. | Apr 2005 | B2 |
6920345 | Al-Ali et al. | Jul 2005 | B2 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6943348 | Coffin IV | Sep 2005 | B1 |
6956649 | Acosta et al. | Oct 2005 | B2 |
6961598 | Diab | Nov 2005 | B2 |
6970792 | Diab | Nov 2005 | B1 |
6985764 | Mason et al. | Jan 2006 | B2 |
6990364 | Ruchti et al. | Jan 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
7003338 | Weber et al. | Feb 2006 | B2 |
7015451 | Dalke et al. | Mar 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
D526719 | Richie, Jr. et al. | Aug 2006 | S |
7096052 | Mason et al. | Aug 2006 | B2 |
7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
D529616 | Deros et al. | Oct 2006 | S |
7133710 | Acosta et al. | Nov 2006 | B2 |
7142901 | Kiani et al. | Nov 2006 | B2 |
7225006 | Al-Ali et al. | May 2007 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7254429 | Schurman et al. | Aug 2007 | B2 |
7254431 | Al-Ali et al. | Aug 2007 | B2 |
7254434 | Schulz et al. | Aug 2007 | B2 |
7274955 | Kiani et al. | Sep 2007 | B2 |
D554263 | Al-Ali et al. | Oct 2007 | S |
7280858 | Al-Ali et al. | Oct 2007 | B2 |
7289835 | Mansfield et al. | Oct 2007 | B2 |
7292883 | De Felice et al. | Nov 2007 | B2 |
7341559 | Schulz et al. | Mar 2008 | B2 |
7343186 | Lamego et al. | Mar 2008 | B2 |
D566282 | Al-Ali et al. | Apr 2008 | S |
7356365 | Schurman | Apr 2008 | B2 |
7371981 | Abdul-Hafiz | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7377794 | Al-Ali et al. | May 2008 | B2 |
7395158 | Monfre et al. | Jul 2008 | B2 |
7415297 | Al-Ali et al. | Aug 2008 | B2 |
7438683 | Al-Ali et al. | Oct 2008 | B2 |
7483729 | Al-Ali et al. | Jan 2009 | B2 |
D587657 | Al-Ali et al. | Mar 2009 | S |
7500950 | Al-Ali et al. | Mar 2009 | B2 |
7509494 | Al-Ali | Mar 2009 | B2 |
7510849 | Schurman et al. | Mar 2009 | B2 |
7514725 | Wojtczuk et al. | Apr 2009 | B2 |
7519406 | Blank et al. | Apr 2009 | B2 |
D592507 | Wachman et al. | May 2009 | S |
7530942 | Diab | May 2009 | B1 |
7593230 | Abul-Haj et al. | Sep 2009 | B2 |
7596398 | Al-Ali et al. | Sep 2009 | B2 |
7606608 | Blank et al. | Oct 2009 | B2 |
7620674 | Ruchti et al. | Nov 2009 | B2 |
D606659 | Kiani et al. | Dec 2009 | S |
7629039 | Eckerbom et al. | Dec 2009 | B2 |
7640140 | Ruchti et al. | Dec 2009 | B2 |
7647083 | Al-Ali et al. | Jan 2010 | B2 |
D609193 | Al-Ali et al. | Feb 2010 | S |
D614305 | Al-Ali et al. | Apr 2010 | S |
7697966 | Monfre et al. | Apr 2010 | B2 |
7698105 | Ruchti et al. | Apr 2010 | B2 |
RE41317 | Parker | May 2010 | E |
RE41333 | Blank et al. | May 2010 | E |
7729733 | Al-Ali et al. | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
7764982 | Dalke et al. | Jul 2010 | B2 |
D621516 | Kiani et al. | Aug 2010 | S |
7791155 | Diab | Sep 2010 | B2 |
RE41912 | Parker | Nov 2010 | E |
7880626 | Al-Ali et al. | Feb 2011 | B2 |
7909772 | Popov et al. | Mar 2011 | B2 |
7919713 | Al-Ali et al. | Apr 2011 | B2 |
7937128 | Al-Ali | May 2011 | B2 |
7937129 | Mason et al. | May 2011 | B2 |
7941199 | Kiani | May 2011 | B2 |
7957780 | Lamego et al. | Jun 2011 | B2 |
7962188 | Kiani et al. | Jun 2011 | B2 |
7976472 | Kiani | Jul 2011 | B2 |
7990382 | Kiani | Aug 2011 | B2 |
8008088 | Bellott et al. | Aug 2011 | B2 |
RE42753 | Kiani-Azarbayjany et al. | Sep 2011 | E |
8028701 | Al-Ali et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8050728 | Al-Ali et al. | Nov 2011 | B2 |
RE43169 | Parker | Feb 2012 | E |
8118620 | Al-Ali et al. | Feb 2012 | B2 |
8130105 | Al-Ali et al. | Mar 2012 | B2 |
8182443 | Kiani | May 2012 | B1 |
8190223 | Al-Ali et al. | May 2012 | B2 |
8203438 | Kiani et al. | Jun 2012 | B2 |
8203704 | Merritt et al. | Jun 2012 | B2 |
8219172 | Schurman et al. | Jul 2012 | B2 |
8224411 | Al-Ali et al. | Jul 2012 | B2 |
8229532 | Davis | Jul 2012 | B2 |
8233955 | Al-Ali et al. | Jul 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8265723 | McHale et al. | Sep 2012 | B1 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8280473 | Ai-Ali | Oct 2012 | B2 |
8315683 | Al-Ali et al. | Nov 2012 | B2 |
RE43860 | Parker | Dec 2012 | E |
8346330 | Lamego | Jan 2013 | B2 |
8353842 | Al-Ali et al. | Jan 2013 | B2 |
8355766 | MacNeish, III et al. | Jan 2013 | B2 |
8374665 | Lamego | Feb 2013 | B2 |
8388353 | Kiani et al. | Mar 2013 | B2 |
8401602 | Kiani | Mar 2013 | B2 |
8414499 | Al-Ali et al. | Apr 2013 | B2 |
8418524 | Al-Ali | Apr 2013 | B2 |
8428967 | Olsen et al. | Apr 2013 | B2 |
8430817 | Al-Ali et al. | Apr 2013 | B1 |
8437825 | Dalvi et al. | May 2013 | B2 |
8455290 | Siskavich | Jun 2013 | B2 |
8457707 | Kiani | Jun 2013 | B2 |
8471713 | Poeze et al. | Jun 2013 | B2 |
8473020 | Kiani et al. | Jun 2013 | B2 |
8509867 | Workman et al. | Aug 2013 | B2 |
8515509 | Bruinsma et al. | Aug 2013 | B2 |
8523781 | Al-Ali | Sep 2013 | B2 |
D692145 | Al-Ali et al. | Oct 2013 | S |
8571617 | Reichgott et al. | Oct 2013 | B2 |
8571618 | Lamego et al. | Oct 2013 | B1 |
8571619 | Al-Ali et al. | Oct 2013 | B2 |
8577431 | Lamego et al. | Nov 2013 | B2 |
8584345 | Al-Ali et al. | Nov 2013 | B2 |
8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
8630691 | Lamego et al. | Jan 2014 | B2 |
8641631 | Sierra et al. | Feb 2014 | B2 |
8652060 | Al-Ali | Feb 2014 | B2 |
8666468 | Ai-Ali | Mar 2014 | B1 |
8670811 | O'Reilly | Mar 2014 | B2 |
RE44823 | Parker | Apr 2014 | E |
RE44875 | Kiani et al. | Apr 2014 | E |
8688183 | Bruinsma et al. | Apr 2014 | B2 |
8690799 | Telfort et al. | Apr 2014 | B2 |
8702627 | Telfort et al. | Apr 2014 | B2 |
8712494 | MacNeish, III et al. | Apr 2014 | B1 |
8715206 | Telfort et al. | May 2014 | B2 |
8723677 | Kiani | May 2014 | B1 |
8740792 | Kiani et al. | Jun 2014 | B1 |
8755535 | Telfort et al. | Jun 2014 | B2 |
8755872 | Marinow | Jun 2014 | B1 |
8764671 | Kiani | Jul 2014 | B2 |
8768423 | Shakespeare et al. | Jul 2014 | B2 |
8771204 | Telfort et al. | Jul 2014 | B2 |
8781544 | Al-Ali et al. | Jul 2014 | B2 |
8790268 | Al-Ali | Jul 2014 | B2 |
8801613 | Al-Ali et al. | Aug 2014 | B2 |
8821397 | Al-Ali et al. | Sep 2014 | B2 |
8821415 | Al-Ali et al. | Sep 2014 | B2 |
8830449 | Lamego et al. | Sep 2014 | B1 |
8840549 | Al-Ali et al. | Sep 2014 | B2 |
8852094 | Al-Ali et al. | Oct 2014 | B2 |
8852994 | Wojtczuk et al. | Oct 2014 | B2 |
8897847 | Al-Ali | Nov 2014 | B2 |
8911377 | Ai-Ali | Dec 2014 | B2 |
8989831 | Al-Ali et al. | Mar 2015 | B2 |
8998809 | Kiani | Apr 2015 | B2 |
9066666 | Kiani | Jun 2015 | B2 |
9066680 | Al-Ali et al. | Jun 2015 | B1 |
9095316 | Welch et al. | Aug 2015 | B2 |
9106038 | Telfort et al. | Aug 2015 | B2 |
9107625 | Telfort et al. | Aug 2015 | B2 |
9131881 | Diab et al. | Sep 2015 | B2 |
9138180 | Coverston et al. | Sep 2015 | B1 |
9153112 | Kiani et al. | Oct 2015 | B1 |
9192329 | Al-Ali | Nov 2015 | B2 |
9192351 | Telfort et al. | Nov 2015 | B1 |
9195385 | Al-Ali et al. | Nov 2015 | B2 |
9211095 | Ai-Ali | Dec 2015 | B1 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9245668 | Vo et al. | Jan 2016 | B1 |
9267572 | Barker et al. | Feb 2016 | B2 |
9277880 | Poeze et al. | Mar 2016 | B2 |
9307928 | Al-Ali et al. | Apr 2016 | B1 |
9323894 | Kiani | Apr 2016 | B2 |
D755392 | Hwang et al. | May 2016 | S |
9326712 | Kiani | May 2016 | B1 |
9392945 | Al-Ali et al. | Jul 2016 | B2 |
9408542 | Kinast et al. | Aug 2016 | B1 |
9436645 | Al-Ali et al. | Sep 2016 | B2 |
9445759 | Lamego et al. | Sep 2016 | B1 |
9474474 | Lamego et al. | Oct 2016 | B2 |
9480435 | Olsen | Nov 2016 | B2 |
9510779 | Poeze et al. | Dec 2016 | B2 |
9517024 | Kiani et al. | Dec 2016 | B2 |
9532722 | Lamego et al. | Jan 2017 | B2 |
9560996 | Kiani | Feb 2017 | B2 |
9579039 | Jansen et al. | Feb 2017 | B2 |
9622692 | Lamego et al. | Apr 2017 | B2 |
D788312 | Al-Ali et al. | May 2017 | S |
9649054 | Lamego et al. | May 2017 | B2 |
9697928 | Al-Ali et al. | Jul 2017 | B2 |
9717458 | Lamego et al. | Aug 2017 | B2 |
9724016 | Al-Ali et al. | Aug 2017 | B1 |
9724024 | Al-Ali | Aug 2017 | B2 |
9724025 | Kiani et al. | Aug 2017 | B1 |
9749232 | Sampath et al. | Aug 2017 | B2 |
9750442 | Olsen | Sep 2017 | B2 |
9750461 | Telfort | Sep 2017 | B1 |
9775545 | Al-Ali et al. | Oct 2017 | B2 |
9778079 | Al-Ali et al. | Oct 2017 | B1 |
9782077 | Lamego et al. | Oct 2017 | B2 |
9787568 | Lamego et al. | Oct 2017 | B2 |
9808188 | Perea et al. | Nov 2017 | B1 |
9839379 | Al-Ali et al. | Dec 2017 | B2 |
9839381 | Weber et al. | Dec 2017 | B1 |
9847749 | Kiani et al. | Dec 2017 | B2 |
9848800 | Lee et al. | Dec 2017 | B1 |
9861298 | Eckerbom et al. | Jan 2018 | B2 |
9861305 | Weber et al. | Jan 2018 | B1 |
9877650 | Muhsin et al. | Jan 2018 | B2 |
9891079 | Dalvi | Feb 2018 | B2 |
9924897 | Abdul-Hafiz | Mar 2018 | B1 |
9936917 | Poeze et al. | Apr 2018 | B2 |
9955937 | Telfort | May 2018 | B2 |
9965946 | Al-Ali et al. | May 2018 | B2 |
D820865 | Muhsin et al. | Jun 2018 | S |
9986952 | Dalvi et al. | Jun 2018 | B2 |
D822215 | Al-Ali et al. | Jul 2018 | S |
D822216 | Barker et al. | Jul 2018 | S |
10010276 | Al-Ali et al. | Jul 2018 | B2 |
10086138 | Novak, Jr. | Oct 2018 | B1 |
10111591 | Dyell et al. | Oct 2018 | B2 |
D833624 | DeJong et al. | Nov 2018 | S |
10123729 | Dyell et al. | Nov 2018 | B2 |
D835282 | Barker et al. | Dec 2018 | S |
D835283 | Barker et al. | Dec 2018 | S |
D835284 | Barker et al. | Dec 2018 | S |
D835285 | Barker et al. | Dec 2018 | S |
10149616 | Al-Ali et al. | Dec 2018 | B2 |
10154815 | Al-Ali et al. | Dec 2018 | B2 |
10159412 | Lamego et al. | Dec 2018 | B2 |
10188348 | Al-Ali et al. | Jan 2019 | B2 |
RE47218 | Al-Ali | Feb 2019 | E |
RE47244 | Kiani et al. | Feb 2019 | E |
RE47249 | Kiani et al. | Feb 2019 | E |
10205291 | Scruggs et al. | Feb 2019 | B2 |
10226187 | Al-Ali et al. | Mar 2019 | B2 |
10231657 | Al-Ali et al. | Mar 2019 | B2 |
10231670 | Blank et al. | Mar 2019 | B2 |
RE47353 | Kiani et al. | Apr 2019 | E |
10279247 | Kiani | May 2019 | B2 |
10292664 | Al-Ali | May 2019 | B2 |
10299720 | Brown et al. | May 2019 | B2 |
10327337 | Schmidt et al. | Jun 2019 | B2 |
10327713 | Barker et al. | Jun 2019 | B2 |
10332630 | Al-Ali | Jun 2019 | B2 |
10383520 | Wojtczuk et al. | Aug 2019 | B2 |
10383527 | Al-Ali | Aug 2019 | B2 |
10388120 | Muhsin et al. | Aug 2019 | B2 |
D864120 | Forrest et al. | Oct 2019 | S |
10441181 | Telfort et al. | Oct 2019 | B1 |
10441196 | Eckerbom et al. | Oct 2019 | B2 |
10448844 | Al-Ali et al. | Oct 2019 | B2 |
10448871 | Al-Ali et al. | Oct 2019 | B2 |
10456038 | Lamego et al. | Oct 2019 | B2 |
10463340 | Telfort et al. | Nov 2019 | B2 |
10471159 | Lapotko et al. | Nov 2019 | B1 |
10505311 | Al-Ali et al. | Dec 2019 | B2 |
10524738 | Olsen | Jan 2020 | B2 |
10532174 | Al-Ali | Jan 2020 | B2 |
10537285 | Shreim et al. | Jan 2020 | B2 |
10542903 | Al-Ali et al. | Jan 2020 | B2 |
10555678 | Dalvi et al. | Feb 2020 | B2 |
10568553 | O'Neil et al. | Feb 2020 | B2 |
10608817 | Haider et al. | Mar 2020 | B2 |
D880477 | Forrest et al. | Apr 2020 | S |
10617302 | Al-Ali et al. | Apr 2020 | B2 |
10617335 | Al-Ali et al. | Apr 2020 | B2 |
10637181 | Al-Ali et al. | Apr 2020 | B2 |
D886849 | Muhsin et al. | Jun 2020 | S |
D887548 | Abdul-Hafiz et al. | Jun 2020 | S |
D887549 | Abdul-Hafiz et al. | Jun 2020 | S |
10667764 | Ahmed et al. | Jun 2020 | B2 |
D890708 | Forrest et al. | Jul 2020 | S |
10721785 | Al-Ali | Jul 2020 | B2 |
10736518 | Al-Ali et al. | Aug 2020 | B2 |
10750984 | Pauley et al. | Aug 2020 | B2 |
D897098 | Al-Ali | Sep 2020 | S |
10779098 | Iswanto et al. | Sep 2020 | B2 |
10827961 | Iyengar et al. | Nov 2020 | B1 |
10828007 | Telfort et al. | Nov 2020 | B1 |
10832818 | Muhsin et al. | Nov 2020 | B2 |
10849554 | Shreim et al. | Dec 2020 | B2 |
10856750 | Indorf et al. | Dec 2020 | B2 |
D906970 | Forrest et al. | Jan 2021 | S |
D908213 | Abdul-Hafiz et al. | Jan 2021 | S |
10918281 | Al-Ali et al. | Feb 2021 | B2 |
10932705 | Muhsin et al. | Mar 2021 | B2 |
10932729 | Kiani et al. | Mar 2021 | B2 |
10939878 | Kiani et al. | Mar 2021 | B2 |
10956950 | Al-Ali et al. | Mar 2021 | B2 |
D916135 | Indorf et al. | Apr 2021 | S |
D917046 | Abdul-Hafiz et al. | Apr 2021 | S |
D917550 | Indorf et al. | Apr 2021 | S |
D917564 | Indorf et al. | Apr 2021 | S |
D917704 | Al-Ali et al. | Apr 2021 | S |
10987066 | Chandran et al. | Apr 2021 | B2 |
10991135 | Al-Ali et al. | Apr 2021 | B2 |
D919094 | Al-Ali et al. | May 2021 | S |
D919100 | Al-Ali et al. | May 2021 | S |
11006867 | Al-Ali | May 2021 | B2 |
D921202 | Al-Ali et al. | Jun 2021 | S |
11024064 | Muhsin et al. | Jun 2021 | B2 |
11026604 | Chen et al. | Jun 2021 | B2 |
D925597 | Chandran et al. | Jul 2021 | S |
D927699 | Al-Ali et al. | Aug 2021 | S |
11076777 | Lee et al. | Aug 2021 | B2 |
11114188 | Poeze et al. | Sep 2021 | B2 |
D933232 | Al-Ali et al. | Oct 2021 | S |
D933233 | Al-Ali et al. | Oct 2021 | S |
D933234 | Al-Ali et al. | Oct 2021 | S |
11145408 | Sampath et al. | Oct 2021 | B2 |
11147518 | Al-Ali et al. | Oct 2021 | B1 |
11185262 | Al-Ali et al. | Nov 2021 | B2 |
11191484 | Kiani et al. | Dec 2021 | B2 |
D946596 | Ahmed | Mar 2022 | S |
D946597 | Ahmed | Mar 2022 | S |
D946598 | Ahmed | Mar 2022 | S |
D946617 | Ahmed | Mar 2022 | S |
11272839 | Al-Ali et al. | Mar 2022 | B2 |
11289199 | Al-Ali | Mar 2022 | B2 |
RE49034 | Al-Ali | Apr 2022 | E |
11298021 | Muhsin et al. | Apr 2022 | B2 |
D950580 | Ahmed | May 2022 | S |
D950599 | Ahmed | May 2022 | S |
D950738 | Al-Ali et al. | May 2022 | S |
D957648 | Al-Ali | Jul 2022 | S |
11382567 | O'Brien et al. | Jul 2022 | B2 |
11389093 | Triman et al. | Jul 2022 | B2 |
11406286 | Al-Ali et al. | Aug 2022 | B2 |
11417426 | Muhsin et al. | Aug 2022 | B2 |
11439329 | Lamego | Sep 2022 | B2 |
11445948 | Scruggs et al. | Sep 2022 | B2 |
D965789 | Al-Ali et al. | Oct 2022 | S |
D967433 | Al-Ali et al. | Oct 2022 | S |
11464410 | Muhsin | Oct 2022 | B2 |
11504058 | Sharma et al. | Nov 2022 | B1 |
11504066 | Dalvi et al. | Nov 2022 | B1 |
D971933 | Ahmed | Dec 2022 | S |
D973072 | Ahmed | Dec 2022 | S |
D973685 | Ahmed | Dec 2022 | S |
D973686 | Ahmed | Dec 2022 | S |
D974193 | Forrest et al. | Jan 2023 | S |
D979516 | Al-Ali et al. | Feb 2023 | S |
D980091 | Forrest et al. | Mar 2023 | S |
11596363 | Lamego | Mar 2023 | B2 |
11627919 | Kiani et al. | Apr 2023 | B2 |
11637437 | Al-Ali et al. | Apr 2023 | B2 |
D985498 | Al-Ali et al. | May 2023 | S |
11653862 | Dalvi et al. | May 2023 | B2 |
D989112 | Muhsin et al. | Jun 2023 | S |
D989327 | Al-Ali et al. | Jun 2023 | S |
11678829 | Al-Ali et al. | Jun 2023 | B2 |
11679579 | Al-Ali | Jun 2023 | B2 |
11684296 | Vo et al. | Jun 2023 | B2 |
11692934 | Normand et al. | Jul 2023 | B2 |
11701043 | Al-Ali et al. | Jul 2023 | B2 |
D997365 | Hwang | Aug 2023 | S |
11721105 | Ranasinghe et al. | Aug 2023 | B2 |
11730379 | Ahmed et al. | Aug 2023 | B2 |
D998625 | Indorf et al. | Sep 2023 | S |
D998630 | Indorf et al. | Sep 2023 | S |
D998631 | Indorf et al. | Sep 2023 | S |
11766198 | Pauley et al. | Sep 2023 | B2 |
D1000975 | Al-Ali et al. | Oct 2023 | S |
11803623 | Kiani et al. | Oct 2023 | B2 |
11832940 | Diab et al. | Dec 2023 | B2 |
20010034477 | Mansfield et al. | Oct 2001 | A1 |
20010039483 | Brand et al. | Nov 2001 | A1 |
20020010401 | Bushmakin et al. | Jan 2002 | A1 |
20020058864 | Mansfield et al. | May 2002 | A1 |
20020133080 | Apruzzese et al. | Sep 2002 | A1 |
20030013975 | Kiani | Jan 2003 | A1 |
20030018243 | Gerhardt et al. | Jan 2003 | A1 |
20030144582 | Cohen et al. | Jul 2003 | A1 |
20030156288 | Barnum et al. | Aug 2003 | A1 |
20030208169 | Chaiken | Nov 2003 | A1 |
20030212312 | Coffin, IV et al. | Nov 2003 | A1 |
20040106163 | Workman, Jr. et al. | Jun 2004 | A1 |
20050055276 | Kiani et al. | Mar 2005 | A1 |
20050234317 | Kiani | Oct 2005 | A1 |
20060073719 | Kiani | Apr 2006 | A1 |
20060189871 | Al-Ali et al. | Aug 2006 | A1 |
20070027376 | Todokoro et al. | Feb 2007 | A1 |
20070073116 | Kiani et al. | Mar 2007 | A1 |
20070123763 | Al-Ali | May 2007 | A1 |
20070180140 | Welch et al. | Aug 2007 | A1 |
20070244377 | Cozad et al. | Oct 2007 | A1 |
20080064965 | Jay et al. | Mar 2008 | A1 |
20080094228 | Welch et al. | Apr 2008 | A1 |
20080103375 | Kiani | May 2008 | A1 |
20080221418 | Al-Ali et al. | Sep 2008 | A1 |
20090036759 | Ault et al. | Feb 2009 | A1 |
20090093687 | Telfort et al. | Apr 2009 | A1 |
20090095926 | MacNeish, III | Apr 2009 | A1 |
20090247984 | Lamego et al. | Oct 2009 | A1 |
20090275844 | Al-Ali | Nov 2009 | A1 |
20100004518 | Vo et al. | Jan 2010 | A1 |
20100030040 | Poeze et al. | Feb 2010 | A1 |
20100099964 | O'Reilly et al. | Apr 2010 | A1 |
20100234718 | Sampath et al. | Sep 2010 | A1 |
20100270257 | Wachman et al. | Oct 2010 | A1 |
20110028806 | Merritt et al. | Feb 2011 | A1 |
20110028809 | Goodman | Feb 2011 | A1 |
20110040197 | Welch et al. | Feb 2011 | A1 |
20110082711 | Poeze et al. | Apr 2011 | A1 |
20110087081 | Kiani et al. | Apr 2011 | A1 |
20110118561 | Tari et al. | May 2011 | A1 |
20110137297 | Kiani et al. | Jun 2011 | A1 |
20110172498 | Olsen et al. | Jul 2011 | A1 |
20120123231 | O'Reilly | May 2012 | A1 |
20120165629 | Merritt et al. | Jun 2012 | A1 |
20120209084 | Olsen et al. | Aug 2012 | A1 |
20120226117 | Lamego et al. | Sep 2012 | A1 |
20120283524 | Kiani et al. | Nov 2012 | A1 |
20130023775 | Lamego et al. | Jan 2013 | A1 |
20130060147 | Welch et al. | Mar 2013 | A1 |
20130096405 | Garfio | Apr 2013 | A1 |
20130296672 | O'Neil et al. | Nov 2013 | A1 |
20130345921 | Al-Ali et al. | Dec 2013 | A1 |
20140166076 | Kiani et al. | Jun 2014 | A1 |
20140180160 | Brown et al. | Jun 2014 | A1 |
20140187973 | Brown et al. | Jul 2014 | A1 |
20140275871 | Lamego et al. | Sep 2014 | A1 |
20140275872 | Merritt et al. | Sep 2014 | A1 |
20140316217 | Purdon et al. | Oct 2014 | A1 |
20140316218 | Purdon et al. | Oct 2014 | A1 |
20140323897 | Brown et al. | Oct 2014 | A1 |
20140323898 | Purdon et al. | Oct 2014 | A1 |
20150005600 | Blank et al. | Jan 2015 | A1 |
20150011907 | Purdon et al. | Jan 2015 | A1 |
20150073241 | Lamego | Mar 2015 | A1 |
20150080754 | Purdon et al. | Mar 2015 | A1 |
20150099950 | Al-Ali et al. | Apr 2015 | A1 |
20170024748 | Haider | Jan 2017 | A1 |
20170231566 | Klimek | Aug 2017 | A1 |
20170251974 | Shreim et al. | Sep 2017 | A1 |
20180242926 | Muhsin et al. | Aug 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20190320906 | Olsen | Oct 2019 | A1 |
20200060869 | Telfort et al. | Feb 2020 | A1 |
20200111552 | Ahmed | Apr 2020 | A1 |
20200113520 | Abdul-Hafiz et al. | Apr 2020 | A1 |
20200138368 | Kiani et al. | May 2020 | A1 |
20200163597 | Dalvi et al. | May 2020 | A1 |
20200253474 | Muhsin et al. | Aug 2020 | A1 |
20200253544 | Belur Nagaraj et al. | Aug 2020 | A1 |
20200275841 | Telfort et al. | Sep 2020 | A1 |
20200288983 | Telfort et al. | Sep 2020 | A1 |
20200329983 | Al-Ali et al. | Oct 2020 | A1 |
20200329993 | Al-Ali et al. | Oct 2020 | A1 |
20210022628 | Telfort et al. | Jan 2021 | A1 |
20210104173 | Pauley et al. | Apr 2021 | A1 |
20210113121 | Diab et al. | Apr 2021 | A1 |
20210117525 | Kiani et al. | Apr 2021 | A1 |
20210121582 | Krishnamani et al. | Apr 2021 | A1 |
20210161465 | Barker et al. | Jun 2021 | A1 |
20210236729 | Kiani et al. | Aug 2021 | A1 |
20210256835 | Ranasinghe et al. | Aug 2021 | A1 |
20210290072 | Forrest | Sep 2021 | A1 |
20210290080 | Ahmed | Sep 2021 | A1 |
20210290120 | Al-Ali | Sep 2021 | A1 |
20210290177 | Novak, Jr. | Sep 2021 | A1 |
20210290184 | Ahmed | Sep 2021 | A1 |
20210296008 | Novak, Jr. | Sep 2021 | A1 |
20210330228 | Olsen et al. | Oct 2021 | A1 |
20210386382 | Olsen et al. | Dec 2021 | A1 |
20210402110 | Pauley et al. | Dec 2021 | A1 |
20220039707 | Sharma et al. | Feb 2022 | A1 |
20220053892 | Al-Ali et al. | Feb 2022 | A1 |
20220071562 | Kiani | Mar 2022 | A1 |
20220096603 | Kiani et al. | Mar 2022 | A1 |
20220151521 | Krishnamani et al. | May 2022 | A1 |
20220218244 | Kiani et al. | Jul 2022 | A1 |
20220287574 | Telfort et al. | Sep 2022 | A1 |
20220296161 | Al-Ali et al. | Sep 2022 | A1 |
20220361819 | Al-Ali et al. | Nov 2022 | A1 |
20220379059 | Yu et al. | Dec 2022 | A1 |
20220392610 | Kiani et al. | Dec 2022 | A1 |
20230028745 | Al-Ali | Jan 2023 | A1 |
20230038389 | Vo | Feb 2023 | A1 |
20230045647 | Vo | Feb 2023 | A1 |
20230058052 | Al-Ali | Feb 2023 | A1 |
20230058342 | Kiani | Feb 2023 | A1 |
20230069789 | Koo et al. | Mar 2023 | A1 |
20230087671 | Telfort et al. | Mar 2023 | A1 |
20230110152 | Forrest et al. | Apr 2023 | A1 |
20230111198 | Yu et al. | Apr 2023 | A1 |
20230115397 | Vo et al. | Apr 2023 | A1 |
20230116371 | Mills et al. | Apr 2023 | A1 |
20230135297 | Kiani et al. | May 2023 | A1 |
20230138098 | Telfort et al. | May 2023 | A1 |
20230145155 | Krishnamani et al. | May 2023 | A1 |
20230147750 | Barker et al. | May 2023 | A1 |
20230210417 | Al-Ali et al. | Jul 2023 | A1 |
20230222805 | Muhsin et al. | Jul 2023 | A1 |
20230222887 | Muhsin et al. | Jul 2023 | A1 |
20230226331 | Kiani et al. | Jul 2023 | A1 |
20230284916 | Telfort | Sep 2023 | A1 |
20230284943 | Scruggs et al. | Sep 2023 | A1 |
20230301562 | Scruggs et al. | Sep 2023 | A1 |
20230346993 | Kiani et al. | Nov 2023 | A1 |
20230368221 | Haider | Nov 2023 | A1 |
20230371893 | Al-Ali et al. | Nov 2023 | A1 |
Number | Date | Country |
---|---|---|
WO 2010082444 | Jul 2010 | WO |
Entry |
---|
Gannon, Mary, “What are the benefits of spring-loaded contacts?”, ConnectorTips.com, Sep. 7, 2016, pp. 6. |
Number | Date | Country | |
---|---|---|---|
20210275101 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
62985164 | Mar 2020 | US |